Orange Book product · Generic (ANDA)
GRIFULVIN V
GRISEOFULVIN, MICROSIZE
At a glance
Jan 26, 1984
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 26, 1984
43 yr ago
Today
Pharmaceutical detail
Active ingredient
GRISEOFULVIN, MICROSIZE
Strength
125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
SUSPENSION
Route
ORAL
TE code
Not listed
Application
ANDA 062483
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of GRISEOFULVIN, MICROSIZE
- 2013GRISEOFULVINGeneric (ANDA)
ANDA 091592 · SANDOZ
- 2012GRISEOFULVINGeneric (ANDA)
ANDA 202482 · SIGMAPHARM LABS LLC
- 2010GRISEOFULVINGeneric (ANDA)
ANDA 065438 · COSETTE PHARMS NC
- 2007GRISEOFULVINGeneric (ANDA)
ANDA 065354 · CIPLA
- 2007GRISEOFULVINGeneric (ANDA)
ANDA 065394 · ACTAVIS MID ATLANTIC
- 2005GRISEOFULVINGeneric (ANDA)
ANDA 065200 · CHARTWELL RX
- —FULVICIN-U/FGeneric (ANDA)
ANDA 060569 · CHARTWELL RX
- —GRIFULVIN VGeneric (ANDA)
ANDA 062279 · VALEANT LUXEMBOURG
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
